Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Shares notification

31 Jan 2007 09:37

ReNeuron Group plc31 January 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer RENEURON GROUP PLCof existing shares to which voting rights are attached 2. Reason for the notification (please tick the appropriate box or boxes)An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which rioting rights are attached An event changing the breakdown of voting rights 3. Full name of person(s) subject to the SAAD INVESTMENTS COMPANY LIMITED notification obligation4. Full name of shareholder(s) (if different from 3.) Vidacos Nominees Ltd (Citigroup Global AWAL)5. Date of the transaction and date on which the Not specified. threshold is crossed or reached6. Date on which issuer notified 30 January 2007 A: Voting rights attached to sharesClass/type Situation Resulting situation after the triggering transaction vi of shares previous to the Triggering if possible transactionusing the ISIN Number of Number Number of Number of voting rights % of voting rightsCODE Shares shares ix of Voting Rights Direct Direct Indirect Direct Indirect Ordinary Shares Not Not 18,950,000 18,950,000 0 15.988% 0 specified specified B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration Exercise/Conversion Number of voting rights % of voting date Period/Date that may be acquired if rightsinstrument the instrument is - exercised/converted N/A - - - - Total (A+B)Number of voting rights % of voting rights 18,950,000 15.988% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable None specified. Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A12. Date on which proxy holder will cease to hold voting N/Arights: 13. Additional information: Recent acquisition. 14. Contact name: Michael Hunt, CEO15. Contact telephone number: 01483 302560 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Feb 20167:00 amRNSNotice of Grant of Key US Patent
12th Jan 20167:00 amRNSPre-clinical data relating to exosome platform
11th Jan 20167:00 amRNSWins UK grant to advance its exosome platform
17th Dec 20157:00 amRNSReNeuron establishes Scientific Advisory Board
7th Dec 20157:00 amRNSInterim Results
4th Dec 20157:00 amRNSNon-executive Director appointment
12th Nov 20152:45 pmRNSNotification of Interim Results
6th Nov 20153:29 pmRNSTotal Voting Rights
2nd Oct 20153:01 pmRNSDirectors' Interest in Shares and Share Options
28th Sep 201512:18 pmRNSBlock Admission and Total Voting Rights
24th Sep 20151:50 pmRNSResult of AGM
24th Sep 20157:00 amRNSAGM Trading Update
1st Sep 20153:22 pmRNSNotification of Major Interest in Shares
28th Aug 20152:45 pmRNSNotification of Major Interest in Shares
28th Aug 20157:00 amRNSNotification of Major Interest in Shares
27th Aug 20157:01 amRNSNotification of Major Interest in Shares
26th Aug 20157:30 amRNSNotification of Major Interest in Shares
26th Aug 20157:00 amRNSPosting of Annual Report and Notice of AGM
25th Aug 201510:00 amRNSCompletion of Placing and TVR
21st Aug 20151:45 pmRNSResult of General Meeting
29th Jul 20154:14 pmRNSPublication of Circular and Notice of GM
10th Jul 20157:01 amRNSPlacing to Raise £68.4 million
10th Jul 20157:00 amRNSPreliminary Results
22nd Jun 20157:00 amRNSExosome Research Collaboration
11th Jun 20157:00 amRNSSenior Management Appointments
29th May 20153:00 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
22nd May 20157:00 amRNSFDA Grants Fast Track Designation
15th May 20157:00 amRNSNotification of Major Interest in Shares
7th May 20157:00 amRNSNotification of Major Interest in Shares
5th May 20157:01 amRNSFDA Approves Start of Phase I/II Trial
22nd Apr 20154:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20154:35 pmRNSPrice Monitoring Extension
17th Apr 201512:15 pmRNSLong Term Clinical Data from PISCES Stroke Trial
13th Apr 20157:00 amRNSIND in the US
1st Apr 20157:00 amRNSReconfigures Board and Strengthens Executive Team
30th Jan 20157:00 amRNSDirector Share Purchases
13th Jan 20153:28 pmRNSNotification of Major Interest in Shares
8th Jan 20152:46 pmRNSNotification of Major Interest in Shares
17th Nov 20147:00 amRNSInterim Results
30th Oct 20147:00 amRNSNotification of Interim Results
14th Oct 20147:00 amRNSNotification of Major Interest in Shares
22nd Sep 20147:00 amRNSDirectors' Interest in Shares and Share Options
15th Sep 201412:15 pmRNSBlock Listing Six Monthly Review
8th Sep 20147:00 amRNSAppointment of CEO
3rd Sep 20147:00 amRNSNotification of Major Interest in Shares
2nd Sep 201411:30 amRNSResult of 2014 Annual General Meeting
2nd Sep 20147:00 amRNSAGM Trading Update
19th Aug 20149:00 amRNSNotification of Major Interest in Shares
25th Jul 20149:59 amRNSDirector/PDMR Shareholding
17th Jul 20149:00 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.